top of page

Search Results

Results found for "Institute for Research in Immunology and Cancer"

  • Dr. Stephane Angers | Dr. GPCR Ecosystem

    Angers established his independent research program in the Department of Pharmaceutical Sciences at the He is the recipient of the Canada Research Chair in Functional Architecture of Signal Transduction. His research program is developed to understand the signaling mechanisms underlying the Wnt and Hedgehog development of novel antibody molecules blocking and activating the Wnt pathway for the treatment of cancers of Toronto, an internationally recognized Research Institute bringing together multidisciplinary teams

  • Brian Arey - Part 2: GPCR Drug Discovery and the Science Nobody Publishes | Dr. GPCR Ecosystem

    receptor signaling, cardiovascular physiology, mechanobiology - that exists in internal reports and institutional In this conversation, Arey traces the full arc of how a pharmaceutical research program is born, resourced led mechanistic pharmacology operations and served as interim head of a 70-person cross-functional research Arey calls this one of the most important and least instinctive skills in pharmaceutical research - and progression - each transition resets the publication clock and delays the depth of specialization that institutional

  • Gunnar Schulte: Frizzled Receptors and the GPCR Identity Question | Dr. GPCR Ecosystem

    Gunnar Schulte of Karolinska Institute makes the case that frizzled receptors are GPCRs — through G-protein Gunnar Schulte's lab at Karolinska Institute has spent years assembling the evidence on the other side Guest Gunnar Schulte is a professor at the Department of Physiology and Pharmacology at Karolinska Institute in Stockholm, where he leads research on Wnt–frizzled receptor signaling. receptors: 10 subtypes, 19 ligands, almost no drugs 20:22 When Wnt–frizzled signaling goes wrong — cancer

  • Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem

    Industry Collaboration How do GPCR tools move from individual academic labs into broad use across the research Joining the conversation are Maria Majellaro (CSO and co-founder of Celtarys Research), Johannes Broichhagen at the CIQUS Research Center in Spain. Johannes Broichhagen is a group leader at the Leibniz Research Institute for Molecular Pharmacology ( Scholar Lab Website Leibniz Research Institute for Molecular Pharmacology (FMP) Profile David Hodson

  • Re-cap of Endocrine Metabolic GPCR 2024 with the Organizers | Dr. GPCR Ecosystem

    UK, Wellcome Trust, and the Medical Research Council. Caroline Gorvin is a Wellcome Trust & Royal Society Sir Henry Dale Fellow at the Institute of Metabolism and Systems Research, University of Birmingham. Caroline moved to the University of Birmingham in 2018 to establish her research group investigating Her current research focuses on how metabolic GPCRs cross-talk and interact to regulate appetite and

  • Dr. Benjamin Myers | Dr. GPCR Ecosystem

    University of Utah School of Medicine in Salt Lake City, UT, and an investigator with the Huntsman Cancer Institute. Ben’s research focuses on Smoothened and other class F GPCRs which play essential roles in embryonic development and in cancer. Ben studied developmental and cancer signaling as a postdoctoral fellow with Philip Beachy at Stanford

  • Pfleger: NanoBRET, Receptor Complexes, and the Translation of GPCR Pharmacology | Dr. GPCR Ecosystem

    Molecular Endocrinology and Pharmacology at the University of Western Australia and the Harry Perkins Institute of Medical Research. That is really why I think most people get into medical research. It's very humbling." Perkins Institute of Medical Research, Deputy Director of the Australian Research Council Centre for Harry Perkins Institute of Medical Research Dr.

  • Dr. Stephen Ferguson | Dr. GPCR Ecosystem

    He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of His research career has focused on the investigation of the regulation of G protein-coupled receptors He currently holds multiple research grants from the Canadian Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor signaling in Huntington’s and Stephen Ferguson on the web Carlton University Canada Research Chairs Twitter ResearchGate LinkedIn Dr

  • Dr. Stephen Ferguson | Dr. GPCR Ecosystem

    He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of His research career has focused on the investigation of the regulation of G protein-coupled receptors He currently holds multiple research grants from the Canadian Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor signaling in Huntington’s and Stephen Ferguson on the web Carlton University Canada Research Chairs Twitter ResearchGate LinkedIn Dr

  • Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    Join the Adhesion GPCR Workshop 2024 in Mexico City at CINVESTAV, bringing together researchers to explore venue, CINVESTAV - Centro de Investigación y de Estudios Avanzados del IPN (in English: Center for Research and Advanced Studies of the National Polytechnic Institute). Instituto Politécnico Nacional no 2508 Mexico City, C.P. 07360 Room: Auditorium Arturo Rosenblueth *Have

  • Masha Niv: Bitter Taste Receptors and the Drug Discovery Blind Spot | Dr. GPCR Ecosystem

    known ligand Extraoral expression of taste GPCRs - physiological roles in the airways, gut, heart, and cancer expressed not only in taste receptor cells on the tongue but in the upper airways, gut, heart, and certain cancer matchmaking challenge 15:53 - Extraoral expression - bitter taste receptors in the airways, gut, heart, and cancer consequences 41:58 - Taste GPCRs as drug targets - asthma, cardiac physiology, and early signals in cancer Masha earned her Bachelor’s degree in chemistry, followed by a direct Ph.D. at the Institute of Chemistry

  • Dr. AurĂ©lien Rizk | Dr. GPCR Ecosystem

    During four years of postdoctoral research at ETH Zurich and the Paul Scherrer Institute in Switzerland Aurélien Rizk on the web InterAx Biotech Paul Scherrer Institut The Org LinkedIn Google Scholar Dr. Cell Signaling and Cancer Metastasis Discussion Aurelien Rizk and Yamina Berchiche had a detailed conversation Yamina shared her research experience, emphasizing the fascination of understanding how cells respond to gradients and signals, particularly in relation to cancer metastasis.

  • Brendan Wilkins | Dr. GPCR Ecosystem

    Since then, Brendan worked as a research assistant at the Victor Chang Cardiac Research Institute where post-doctoral positions to begin in mid-2024" Brendan Wilkins on the web UNSW Sydney Google Scholar ResearchGate

  • Dr. Bianca Plouffe | Dr. GPCR Ecosystem

    After obtaining a Postdoctoral Fellowship from the Canadian Institutes of Health Research in 2012, Bianca joined the research group of Prof Michel Bouvier at UniversitĂ© de MontrĂ©al. In 2018, Bianca was appointed Vice-Chancellor’s Fellow at Queen’s University Belfast to develop her research Bianca Plouffe on the web Queen's University Belfast website LinkedIn ResearchGate ORCID Dr.

  • Dr. Marta Filizola | Dr. GPCR Ecosystem

    The overall goal of her research program is to obtain rigorous mechanistic insights into the structure at the Second University of Naples and a postdoctorate in Computational Biophysics at the Molecular Research Institute in California, USA. Filizola on the web Icahn School of Medicine at Mount Sinai Filizola Lab Wikipedia Twitter Linkedin ResearchGate

  • Alexander Hauser: GPCR Pharmacogenomics and Precision Psychiatry | Dr. GPCR Ecosystem

    Hauser's research program asks a pointed question: if a patient fails to respond to a psychiatric drug of Drug Design and Pharmacology, with a part-time affiliation at the Institute for Biological Psychiatry Research that bypasses clinical input tends to stay in the research community. Alexander is currently a postdoc as a member of the personalized medicine cluster in Copenhagen and at the Institute He received the “HC Ørsted Research talent prize” and “Bayer Pharmaceuticals Ph.D.

  • Dr. Mark Connor | Dr. GPCR Ecosystem

    Grant-funded independent research positions from 2001 at University of Sydney (opioids and sensory neurons ), Vollum Institute Portland (visiting scientist with Ed McCleskey, sensory neuron properties); Pain Management Research Institute (more opioids, cannabinoids and T-type Ca channels) and Brain and Mind Research Institute (Sydney). 2009, appointed Professor of Pharmacology at Macquarie University. Mark Connor on the web Researchers Twitter Google Scholar Dr. GPCR Ecosystem Unlock the Full Dr.

  • InĂȘs Pinheiro, Monserrat Avila Zozaya & Yamina Berchiche | Dr. GPCR Ecosystem

    As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the University of Montreal in Canada before training at The Rockefeller University in New York and the National Institutes Yamina Berchiche on the web Website LinkedIn Facebook Twitter ResearchGate PubMed Google Scholar Dr.

  • Antonella Di Pizio: Computational Pharmacology of Taste and Olfactory Receptors | Dr. GPCR Ecosystem

    Antonella Di Pizio is an independent research group leader in computational pharmacology at the Leibniz leader appointed to the institute's newly-formed in-silico department. "You share your research goal with your collaborators. They are more partners than collaborators." Antonella Di Pizio, an independent research group leader at the Leibniz Institute for Food Systems Biology Today, Antonella has expanded her research to olfactory GPCRs and trace amine receptors.

  • Arun Shukla: How Two Arrestins Regulate 800 GPCRs | Dr. GPCR Ecosystem

    He completed his PhD at the Max Planck Institute of Biophysics in Frankfurt and postdoctoral training Shukla wasn't sure research would be his career. Arun Shukla from the Indian Institute of Technology in Kanpur, India. Shukla’s research and how working in the lab instead of going to classes made him realize that research Arun Shukla on the web Indian Institute of Technology Dr.

  • Dr. Randy Hall | Dr. GPCR Ecosystem

    After obtaining his Ph.D. in 1994, Randy moved to the Vollum Institute in Portland, Oregon, to do a post-doctoral Randy has received a number of research prizes, including the PhRMA New Investigator Award, the Distinguished Young Scholar in Medical Research Award from the W.M. Randy Hall on the web Hall Lab LinkedIn Google Scholar ResearchGate Dr. Lefkowitz Memoir. Dr.

  • University Pricing | Dr. GPCR Ecosystem

    All these benefits are designed to enhance your research experience and keep you informed about the latest Valid until canceled Join Premium Today! Find the right plan for your team — from small groups to institution-wide access. One insight, one connection, one 'aha' moment — can save months of research time. opportunities, and tools to accelerate GPCR-related research and career growth.

  • Dr. Evi Kostenis | Dr. GPCR Ecosystem

    in vitro Pharmacology at 7TM Pharma in Denmark; Full professor, department chair and director of the institute Research interests: Signaling mechanisms involving GPCRs and heterotrimeric G proteins" Dr. Evi Kostenis on the web University of Bonn ResearchGate LinkedIn Dr. GPCR Unlock the Full Dr.

  • Chemical Probes for GPCR Imaging and Internalization with Dr. Johannes Broichhagen | Dr. GPCR Ecosystem

    His postdoctoral training included research at the École Polytechnique FĂ©dĂ©rale de Lausanne (2015–2016 ) and later at the Max Planck Institute for Medical Research in Heidelberg, where he served as both postdoc Since 2020, JB has led his research group at the Leibniz Research Institute for Molecular Pharmacology Johannes Broichhagen on the Web LinkedIn Google Scholar Lab Website Leibniz Research Institute for Molecular

  • Leadership, Impact, and GPCR Signaling with Dr. Michelle Halls | Dr. GPCR Ecosystem

    How an integrated training and lab structure at Monash Institute of Pharmaceutical Sciences fosters innovation in functional assay development and GPCR research. Associate Professor at Monash University and Deputy Theme Leader of Drug Discovery Biology at Monash Institute She established her lab in 2011, and today she is a Viertel Senior Medical Research Fellow. More about Michelle Halls Monash Institute of Pharmaceutical Sciences Bluesky LinkedIn Articles about

  • Dr. Arthur Christopoulos | Dr. GPCR Ecosystem

    GPCR researchers in Australia and the initiation of a successful series of conferences. Additionally, they explored the unique culture and structure of their Institute, highlighting its translational approach to research and its capacity to translate research into therapeutic commercialization. Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, , highlighting the unique opportunities presented by their location and partnerships with other institutions

  • Dr. Arthur Christopoulos | Dr. GPCR Ecosystem

    GPCR researchers in Australia and the initiation of a successful series of conferences. Additionally, they explored the unique culture and structure of their Institute, highlighting its translational approach to research and its capacity to translate research into therapeutic commercialization. Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, , highlighting the unique opportunities presented by their location and partnerships with other institutions

  • Dr. Yamina Berchiche | Dr. GPCR Ecosystem

    GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the University of Montreal in Canada before training at Rockefeller University in New York and the National Institutes Yamina Berchiche on the web Website LinkedIn Facebook Twitter ResearchGate PubMed Google Scholar Dr.

  • Sam Hoare: Receptor Residence Time and GPCR Data Analysis | Dr. GPCR Ecosystem

    allosteric modulation of dopamine receptors in Philip Strange's UK lab and a postdoc at the National Institutes His independent research focuses on developing accessible mathematical tools for kinetic analysis of His ongoing research exists to close that gap. 3. Early-Career Researchers Know More Than They Think Hoare makes an argument that surprised him when he He then moved to the National Institute of Mental Health, researching pharmacological mechanisms of Class

  • Dr. John Streicher: Reorganizing Opioid Signaling Beyond the Receptor | Dr. GPCR Ecosystem

    Laura Bohn at Scripps Research Institute. opioid antinociception in one context, drives chronic pain in another, and functions as a mitogen in cancer A trained pharmacologist's first instinct is that the side effect burden would be crushing. Laura Bohn’s lab at Scripps Research Institute in Florida.

bottom of page